Managing SMA Patients During the COVID-19 Pandemic – CureSMA

Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis
Brain Penetrant BTK Update: Reducing Neuroinflammation to Optimize Outcomes for Patients with Multiple Sclerosis
Clinical Update on Anti-CD20 Therapeutics for Patients with Relapsing Multiple Sclerosis

811 South Orleans Avenue
Tampa, FL 33606

Office: 610.687.3300
[email protected]